Martin Holst Lange

Martin Holst Lange is an experienced professional who has been with Novo Nordisk since 2003. Currently, Martin Holst holds the position of Executive Vice President, Development at Novo Nordisk A/S, overseeing global clinical development and project management for the company's portfolio of development projects in various chronic diseases. Prior to this role, Martin Holst served as Corporate Project Vice President and Vice President in the Global Development division. With a strong educational background in Endocrinology and Medicine from the University of Copenhagen, Martin is a valuable member of Novo Nordisk's Management Board and various committees.